Damora Therapeutics (DMRA) EPS (Basic) (2019 - 2026)
Damora Therapeutics (DMRA) posted EPS (Basic) of -$0.81 for Q1 2026, up 99.44% on a QoQ basis from -$144.44 in Q4 2025, and up 57.72% year-over-year from -$0.51 in Q1 2025.
Damora Therapeutics (DMRA) EPS (Basic) (2019 - 2026) Analysis & Trends
Damora Therapeutics' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$0.81 for Q1 2026.
- Quarterly EPS (Basic) rose 57.72% year-over-year to -$0.81 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.74 (up 51.81% YoY) and the FY2025 annual result came in at -$151.12, down 715.66% from the prior year.
- EPS (Basic) was -$0.81 for Q1 2026 at Damora Therapeutics, up from -$144.44 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.06 in Q4 2023 and bottomed at -$144.44 in Q4 2025.
- A 5-year average of -$9.73 and a median of -$0.68 in 2022 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) soared 111.65% — and 2024, when it slumped 9385.82%.
- Damora Therapeutics' EPS (Basic) stood at -$0.54 in 2022, then jumped by 111.65% to $0.06 in 2023, then sank by 9385.82% to -$5.83 in 2024, then tumbled by 2379.48% to -$144.44 in 2025, then soared by 99.44% to -$0.81 in 2026.
- Business Quant data shows DMRA's EPS (Basic) at -$0.81 in Q1 2026, -$144.44 in Q4 2025, and -$2.36 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Damora Therapeutics | 1.00 Bn | 798.11 Mn | - | -0.81 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.81 |
| Dec 31, 2025 | -144.44 |
| Sep 30, 2025 | -2.36 |
| Jun 30, 2025 | -2.60 |
| Mar 31, 2025 | -1.92 |
| Dec 31, 2024 | -5.83 |
| Sep 30, 2024 | -3.39 |
| Jun 30, 2024 | -0.20 |
| Mar 31, 2024 | -0.20 |
| Dec 31, 2023 | 0.06 |
| Sep 30, 2023 | -0.30 |
| Jun 30, 2023 | -0.41 |
| Mar 31, 2023 | -0.58 |
| Dec 31, 2022 | -0.54 |
| Sep 30, 2022 | -0.54 |
| Jun 30, 2022 | -0.68 |
| Mar 31, 2022 | -0.68 |
| Dec 31, 2021 | -0.54 |
| Sep 30, 2021 | -0.50 |
| Jun 30, 2021 | -0.64 |